Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,549,032
+$9,807,354 QoQ
Shares Held
49,869
+295.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#805
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $290,206,318 across 12 Drug Manufacturers - General names. ABBV ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
411,773 | $78,080,395 | |
| 2 | LLY |
ELI LILLY & Co
|
52,884 | $63,430,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
399,582 | $51,346,286 | |
| 4 | PFE |
Pfizer Inc
|
1,455,651 | $35,052,075 | |
| 5 | JNJ |
Johnson & Johnson
|
78,892 | $20,036,200 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
49,869 | $12,549,032 | |
| 7 | BIIB |
Biogen Inc.
|
56,064 | $12,113,187 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
83,510 | $10,550,651 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,549,032 | 49,869 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,741,678 | 12,606 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,377,995 | 14,784 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,098,089 | 30,656 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,335,646 | 28,745 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,509,995 | 31,071 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,737,837 | 26,662 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,232,232 | 26,495 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,910,691 | 16,970 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,662,029 | 20,110 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,842,479 | 24,795 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,156,238 | 27,883 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,513,083 | 26,075 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,334,929 | 14,651 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,789,958 | 29,639 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,644,739 | 27,157 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,064,557 | 26,538 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,605,000 | 22,238 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,728,245 | 12,764 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $905,782 | 8,397 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $785,776 | 6,976 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $744,661 | 6,881 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $486,568 | 4,541 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $473,598 | 5,407 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $530,858 | 5,407 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $576,300 | 7,564 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||